| Slide Title | Slide Name | Revision Date |
|---|
| Neuropharmacology of Antiepileptic Drugs | | February 2008 |
| Definitions | | |
| Antiepileptic Drug | | |
| History of Antiepileptic Drug Therapy in the U.S. | | |
| History of Antiepileptic Drug Therapy in the U.S. | | |
| Molecular and Cellular Mechanisms | | |
| Molecular and Cellular Mechanisms | | |
| Molecular and Cellular Mechanisms | | |
| Molecular and Cellular Mechanisms | | |
| Molecular and Cellular Mechanisms | | |
| Molecular and Cellular Mechanisms | | |
| Molecular and Cellular Mechanisms | | |
| Molecular and Cellular Mechanisms | | |
| Summary: Mechanisms of Neuromodulation | | |
| Cellular Mechansims of Seizure Generation | | |
| Epilepsy - GABA | | |
| Epilepsy - GABA | | |
| Epilepsy - Glutamate | | |
| Epilepsy - Glutamate | | |
| Molecular and Cellular Mechanisms Overview | | |
| Molecular and Cellular Mechanisms Overview | | |
| Epilepsy Trivia | | |
| Epilepsy Trivia | | |
| Pharmacokinetic Principles | | |
| Pharmacokinetic Principles | | |
| Drug Metabolizing Enzymes: UDP | | |
| The Cytochrome P-450 Isozyme System | | |
| Drug Metabolizing Isozymes and AEDs | | |
| AED Inducers: The Cytochrome P-450 Enzyme System | | |
| AED Inducers: The Cytochrome P-450 Enzyme System | | |
| AED Inhibitors: The Cytochrome P-450 Enzyme System | | |
| AED Inhibitors: The Cytochrome P-450 Enzyme System | | |
| Therapeutic Index | | |
| Steady State and Half Life | | |
| AED Serum Concentrations | | |
| AED Serum Concentrations | | |
| Potential Target Range of AED Serum Concentrations | | |
| Potential Target Range of AED Serum Concentrations | | |
| Admixture and Administration of Injectable AEDs | | |
| Comparative Pharmacokinetics of Traditional AEDs | | |
| Pharmacokinetics of Newer AEDs | | |
| Pharmacodynamic Interactions | | |
| Pharmacokinetic Factors in the Elderly | | |
| Pharmacokinetic Factors in Pediatrics | | |
| Pharmacokinetics in Pregnancy | | |
| Metabolic Changes of AEDs | | |
| Metabolic Changes of AEDs | | |
| Effects of Dialysis | | |
| Hepatic Drug Matabloizing Enzymes and Specific AED Interactions | | |
| Isozyme Specific Drug Interactions | | |
| AEDs and Drug Interactions | | |
| Pharmacokinetic Interactions: Possible Clinical Scenarios | | |
Adverse Effects | Slide053.ppt | February 2008 |
Acute, Dose-related Adverse Effects of AEDs | Slide054.ppt | February 2008 |
Acute, Dose-related Adverse Effects of AEDs (Con't) | Slide055.ppt | February 2008 |
Acute, Dose-related Adverse Effects of AEDs (Con't) | Slide056.ppt | February 2008 |
Acute, Dose-related Adverse Effects of AEDs (Con't) | Slide057.ppt | February 2008 |
Idiosyncratic Adverse Effects of AEDs | Slide058.ppt | February 2008 |
Stevens-Johnson Syndrome | Slide059.ppt | February 2008 |
Idiosyncratic Adverse Effects of AEDs | Slide060.ppt | February 2008 |
Long-term Adverse Effects of AEDs | Slide061.ppt | February 2008 |
Gingival Hyperplasia Induced by Phenytoin | Slide062.ppt | February 2008 |
After Withdrawal of Phenytoin | Slide063.ppt | February 2008 |
Trabecular Bone | Slide064.ppt | February 2008 |
AED Hypersensitivity Syndrome | Slide065.ppt | February 2008 |
AED Hypersensitivity | Slide066.ppt | February 2008 |
Epilepsy Trivia | Slide067.ppt | February 2008 |
Epilepsy Trivia | Slide068.ppt | February 2008 |
Pharmacology Resident Case Studies | Slide069.ppt | February 2008 |
Case #1 Pediatric | Slide070.ppt | February 2008 |
Case #1 Pediatric (Con't) | Slide071.ppt | February 2008 |
Case #1 Pediatric (Con't) | Slide072.ppt | February 2008 |
Case #1 Pediatric (Con't) | Slide073.ppt | February 2008 |
Case #1 Pediatric (Con't) | Slide074.ppt | February 2008 |
